No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Dnake (300884.SZ) issued a profit warning, expecting a net loss of 8 million yuan to -16 million yuan for the year 2024, turning from profit to loss.
Dnake (300884.SZ) announced its performance forecast for 2024, and the company expects that the net profit attributable to shareholders for the year 2024 will be...
Dineck: 2024 Annual Results Forecast
dnake (300884.SZ): Has cumulatively repurchased 1.86% of its shares.
On January 3, Gelonghui reported that Dnake (300884.SZ) announced that as of December 31, 2024, the company has repurchased 4,729,040 shares through a dedicated securities account for share buybacks via centralized bidding, accounting for 1.8628% of the company's total share capital, with a highest Fill Price of 10.30 yuan/share, a lowest Fill Price of 7.39 yuan/share, and a total amount of funds used of 43.1753 million yuan (excluding transaction costs).
Dnake (300884.SZ): The core positioning of the company's Asia Vets Logistics robot products is to provide efficient Medical supply delivery services for various indoor scenarios in Hospitals.
On December 20, Glonghui reported that Dnake (300884.SZ) stated on the investor interaction platform that the current core positioning of its Asia Vets Logistics robot products being introduced to the market is to provide efficient Medical supply delivery services for various indoor scenarios in Hospitals. The main application scenarios include laboratories, central pharmacies, inpatient departments, and operating rooms. In the future, the company will also actively explore adapting to more Logistics delivery scenarios such as Community, hotels, and parks to meet broader market demands.
Dnake (300884.SZ): The company's medical intercom system has been implemented in several retirement homes across the country.
On December 20, Glance Research reported that Dnake (300884.SZ) stated on the investor interaction platform that the company always closely follows national policy guidance and industry development trends. Based on the existing mature medical intercom system, it integrates Asia Vets functionalities and needs, and gradually extends the smart medical product line to retirement homes and at-home retirement services to meet the growing demand in the retirement market. The company's medical intercom system has already been implemented in multiple retirement homes across the country. In the future, the company hopes to further integrate Asia Vets technology and services, expanding its product line and service scope to a broader retirement field, creating new opportunities for the company.
Dnake (300884.SZ) has appointed Wang Yueshan as the financial director.
Dnake (300884.SZ) announced that the company's Board of Directors has approved the appointment of Wang Yuxian as the company's Chief Financial Officer, and appointed Hu Chuan...
